Fred Alger Management, LLC Compass Therapeutics, Inc. Transaction History

Fred Alger Management, LLC

  • $19.8 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
SELL
$3.14 - $5.48 $645,188 - $1.13 Million
-205,474 Reduced 33.77%
403,062 $1.32 Million
Q1 2022

May 16, 2022
SELL
$1.25 - $3.5 $262,761 - $735,731
-210,209 Reduced 25.67%
608,536 $834,000
Q4 2021

Feb 14, 2022
BUY
$2.88 - $3.98 $2.36 Million - $3.26 Million
818,745 New
818,745 $2.6 Million

Others Institutions Holding CMPX

# of Institutions
79
Shares Held
91.9M
Call Options Held
0
Put Options Held
0
View Full List

About Compass Therapeutics, Inc.

CMPX Quotes by TradingView
  • Ticker CMPX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 101,285,000
  • Market Cap $139M
  • Description
  • Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company's product candidates in the clinical stage of development include CTX-009, an investigational bispecific antibody that blocks Delta-like ligand 4/Notch and vascula...
More about CMPX
Track This Portfolio

Track Fred Alger Management, LLC Portfolio

Follow Fred Alger Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fred Alger Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email